Clinical Trial Update: A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal Osteoporosis [Phase 3]

View source ↗

Summary

Phase 3 trial results for ibandronate (Boniva) in bisphosphonate-naïve postmenopausal osteoporosis have been completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Boniva (ibandronate)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Post Menopausal Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2015-08-13